The reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.73BCNY
1.30B · vs all stocks (USD)
Updated Nov 22, 2026
Revenue (TTM)
615.52MCNY
103.14M · vs all stocks (USD)
Updated Nov 22, 2026
Profit Margin
-18.34%
vs Aerospace & Defense peers
Updated Nov 22, 2026
Beta
0.0600x
vs all stocks
Updated Nov 22, 2026
52-Week Change
-55.75%
vs all stocks
Updated Nov 22, 2026
Market Capitalization
6.73BCNY
1.30B · vs all stocks (USD)
Updated Nov 22, 2026
Enterprise Value
6.62BCNY
1.27B · vs all stocks (USD)
Updated Nov 22, 2026
Forward P/E
203.00x
vs Aerospace & Defense peers
Updated Nov 22, 2026
Price to Sales (TTM)
10.93x
vs Aerospace & Defense peers
Updated Nov 22, 2026
Price to Book (MRQ)
4.57x
vs Aerospace & Defense peers
Updated Nov 22, 2026
Enterprise to Revenue
10.76x
vs Aerospace & Defense peers
Updated Nov 22, 2026
Gross Margin
38.49%
vs Aerospace & Defense peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 31.36%.Updated Nov 22, 2026
Profit Margin
-18.34%
vs Aerospace & Defense peers
Updated Nov 22, 2026
Operating Margin
-16.29%
vs Aerospace & Defense peers
Updated Nov 22, 2026
Return on Assets (TTM)
-2.60%
vs Aerospace & Defense peers
Updated Nov 22, 2026
Return on Equity (TTM)
-7.30%
vs Aerospace & Defense peers
Updated Nov 22, 2026
Revenue (TTM)
615.52MCNY
103.14M · vs all stocks (USD)
Updated Nov 22, 2026
Revenue per Share (TTM)
0.8870CNYUpdated Nov 22, 2026
Quarterly Revenue Growth
-31.30%
vs Aerospace & Defense peers
Updated Nov 22, 2026
Gross Profit (TTM)
193.01MCNY
27.85M · vs all stocks (USD)
Updated Nov 22, 2026
EBITDA (TTM)
78.70MCNY
11.80M · vs all stocks (USD)
Updated Nov 22, 2026
Net Income (TTM)
-112.88MCNY
-16.22M · vs all stocks (USD)
Updated Nov 22, 2026
Quarterly Earnings Growth (YoY)
-72.80%
vs Aerospace & Defense peers
Updated Nov 22, 2026
Operating Cash Flow (TTM)
138.87MCNY
27.73M · vs all stocks (USD)
Updated Nov 22, 2026
Levered Free Cash Flow (TTM)
-25.86MCNY
2.01M · vs all stocks (USD)
Updated Nov 22, 2026
5-Year Average Dividend Yield
0.09%
vs all stocks
Updated Nov 22, 2026
Payout Ratio
0.00%
vs Aerospace & Defense peers
Updated Nov 22, 2026
Minority Interest (Equity)
9.93MCNYFY2025 · Dec 31, 2025
Revenue
781.59MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
549.42MCNYFY2025 · Dec 31, 2025
Gross Profit
232.17MCNYFY2025 · Dec 31, 2025
Operating Income
-34.38MCNY
-5.15M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-76.94MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-7.54MCNYFY2025 · Dec 31, 2025
Net Income
-69.41MCNYFY2025 · Dec 31, 2025
EBIT
-75.79MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
78.70MCNYFY2025 · Dec 31, 2025
Research & Development
70.36MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
33.03MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
4.66MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
660.30KCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
1.15MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.1000CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.1000CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
692.24MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
692.24MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-69.41MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
183.34KCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
14.79MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-182.00MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
245.81MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-69.41MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
4.98MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-77.71MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
156.93MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-196.79MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-752.92MCNYFY2025 · Dec 31, 2025
Sale of Investments
753.59MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-196.11MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
41.17MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-21.00MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-2.10MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-5.71MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
12.36MCNYFY2025 · Dec 31, 2025
Shares Outstanding
662.68MSharesUpdated Nov 22, 2026
Float Shares
455.90MSharesUpdated Nov 22, 2026
% Held by Insiders
31.38%
vs all stocks
Updated Nov 22, 2026
% Held by Institutions
4.33%
vs all stocks
Updated Nov 22, 2026
Total Cash (MRQ)
226.41MCNY
37.45M · vs all stocks (USD)
Updated Nov 22, 2026
Total Cash per Share (MRQ)
0.3420CNYUpdated Nov 22, 2026
Total Debt (MRQ)
96.08MCNY
10.83M · vs all stocks (USD)
Updated Nov 22, 2026
Total Debt to Equity (MRQ)
0.0641x
vs Aerospace & Defense peers
Updated Nov 22, 2026
Current Ratio (MRQ)
1.67x
vs Aerospace & Defense peers
Updated Nov 22, 2026
Book Value per Share (MRQ)
2.22CNYUpdated Nov 22, 2026
Total Assets
2.40BCNY
360.06M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.23BCNYFY2025 · Dec 31, 2025
Total Liabilities
863.67MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.18BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
141.61MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
722.06MCNYFY2025 · Dec 31, 2025
Cash
245.81MCNYFY2025 · Dec 31, 2025
Cash Equivalents
3.68MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
249.50MCNYFY2025 · Dec 31, 2025
Accounts Receivable
383.06MCNYFY2025 · Dec 31, 2025
Inventory
413.32MCNYFY2025 · Dec 31, 2025
Accounts Payable
453.84MCNYFY2025 · Dec 31, 2025
Short-term Debt
45.02MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
9.15MCNYFY2025 · Dec 31, 2025
Long-term Debt
10.61MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
3.34MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
662.68MCNYFY2025 · Dec 31, 2025
Retained Earnings
-226.02MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.54BCNY
230.61M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
10.14CNYUpdated Nov 22, 2026
52-Week High
38.60CNYUpdated Nov 22, 2026
52-Week Change
-55.75%
vs all stocks
Updated Nov 22, 2026
Beta
0.0600x
vs all stocks
Updated Nov 22, 2026
50-Day MA
12.41CNYUpdated Nov 22, 2026
200-Day MA
17.56CNYUpdated Nov 22, 2026
Avg 10-Day Volume
39.79MSharesUpdated Nov 22, 2026
Avg 30-Day Volume
61.44MSharesUpdated Nov 22, 2026
Diluted EPS (TTM)
-0.1700CNYUpdated Nov 22, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.